AZD-3427

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameAZD-3427
Drug Alias NameAZD-3427
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionRelaxin replacements
TargetsRelaxin
Therapy Area/IndicationsHeart Failure, SystolicHeart FailureRenal Insufficiency +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAstrazeneca Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcAstrazeneca AbAstraZeneca global R & D (China) Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHeart FailureHypertension, Pulmonary
Inactive IndicationsHeart Failure, SystolicRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A